Featured Research

from universities, journals, and other organizations

Adding dexmedetomidine reduces anesthesia dose required for surgery

Date:
April 11, 2014
Source:
International Anesthesia Research Society (IARS)
Summary:
For patients undergoing surgery, adding a sedative drug called dexmedetomidine can reduce the necessary doses of other anesthetic drugs, reports a study. The results of this randomized trials show that a relatively low dose of dexmedetomidine can reduce anesthetic dose while also helping to control pain after surgery, without prolonging recovery time.

For patients undergoing surgery, adding a sedative drug called dexmedetomidine can reduce the necessary doses of other anesthetic drugs, reports a study in the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

Related Articles


Using dexmedetomidine as an adjuvant (additional) agent can not only lower the anesthetic dose but also delay the time until strong pain relievers are needed after surgery, according to the new research by Dr Marc Fischler of Hτpital Foch, Suresnes, France, and colleagues.

Objective Assessment of Adjuvant Dexmedetomidine

The study included 60 patients undergoing surgery and anesthesia with two widely used intravenous anesthetic drugs: propofol and remifentanil. Patients were randomly assigned to receive the commonly used sedative drug dexmedetomidine, or an inactive placebo (saline solution).

The doses of propofol and remifentanil required for surgery were compared between groups. The anesthetics were given through an automated "closed-loop" system, which adjusted doses according to a measure of brain activity (the bispectral index) to precisely maintain a target level of anesthesia. This provided an objective measure of depth of anesthesia, minimizing variations in anesthetic dose.

The amounts of anesthetic drugs needed to induce anesthesia were significantly lower in patients receiving dexmedetomidine. The propofol induction dose was 30 percent lower and the remifentanil induction dose 25 percent lower, compared to patients receiving placebo.

The propofol dose needed to maintain the desired level of anesthesia was also about 30 percent lower in the dexmedetomidine group. The maintenance remifentanil dose was unaffected by dexmedetomidine.

Dexmedetomidine Also Helps Control Pain After Surgery

There was also evidence of an analgesic (pain-relieving) effect of dexmedetomidine. The median time to the first patient request for morphine was four hours after surgery in the dexmedetomidine group, compared to one hour in the placebo group.

There was no difference in recovery time, and no increase in the rate of delayed recovery, among patients receiving dexmedetomidine. Other adverse effects were also similar in the dexmedetomidine and placebo groups.

Dexmedetomidine is commonly used as a sedative for patients receiving mechanical ventilation in the intensive care unit. An alpha-2 adrenergic agonist, dexmedetomidine acts through a different mechanism than propofol or other anesthetics, suggesting that it might be a useful supplement for anesthesia.

Previous studies have that dexmedetomidine can reduce anesthetic and analgesic doses in patients undergoing surgery. However, the new study is the first to show an "anesthetic-sparing" effect using the bispectral index as an objective measure of anesthetic requirements.

The results of this randomized trials show that a relatively low dose of dexmedetomidine can reduce anesthetic dose while also helping to control pain after surgery, without prolonging recovery time. Dr Fischler and coauthors conclude, "Dexmedetomidine is a useful adjuvant that reduces anesthetic requirement and provides postoperative analgesia," Dr Fischler and coauthors conclude.


Story Source:

The above story is based on materials provided by International Anesthesia Research Society (IARS). Note: Materials may be edited for content and length.


Journal Reference:

  1. Morgan Le Guen, Ngai Liu, Felix Tounou, Marion Augι, Olivier Tuil, Thierry Chazot, Dominique Dardelle, Pierre-Antoine Laloλ, Francis Bonnet, Daniel I. Sessler, Marc Fischler. Dexmedetomidine Reduces Propofol and Remifentanil Requirements During Bispectral Index-Guided Closed-Loop Anesthesia. Anesthesia & Analgesia, 2014; 1 DOI: 10.1213/ANE.0000000000000185

Cite This Page:

International Anesthesia Research Society (IARS). "Adding dexmedetomidine reduces anesthesia dose required for surgery." ScienceDaily. ScienceDaily, 11 April 2014. <www.sciencedaily.com/releases/2014/04/140411153455.htm>.
International Anesthesia Research Society (IARS). (2014, April 11). Adding dexmedetomidine reduces anesthesia dose required for surgery. ScienceDaily. Retrieved December 21, 2014 from www.sciencedaily.com/releases/2014/04/140411153455.htm
International Anesthesia Research Society (IARS). "Adding dexmedetomidine reduces anesthesia dose required for surgery." ScienceDaily. www.sciencedaily.com/releases/2014/04/140411153455.htm (accessed December 21, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, December 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) — A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) — Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Reuters - Innovations Video Online (Dec. 21, 2014) — A team of scientists led by Danish chemist Jorn Christensen says they have isolated two chemical compounds within an existing antipsychotic medication that could be used to help a range of failing antibiotics work against killer bacterial infections, such as Tuberculosis. Jim Drury went to meet him. Video provided by Reuters
Powered by NewsLook.com
Hugging It Out Could Help You Ward Off A Cold

Hugging It Out Could Help You Ward Off A Cold

Newsy (Dec. 21, 2014) — Carnegie Mellon researchers found frequent hugs can help people avoid stress-related illnesses. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins